689 related articles for article (PubMed ID: 33579825)
1. METTL3-dependent N
Chien CS; Li JY; Chien Y; Wang ML; Yarmishyn AA; Tsai PH; Juan CC; Nguyen P; Cheng HM; Huo TI; Chiou SH; Chien S
Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33579825
[TBL] [Abstract][Full Text] [Related]
2. RNA
Li B; Zhang T; Liu M; Cui Z; Zhang Y; Liu M; Liu Y; Sun Y; Li M; Tian Y; Yang Y; Jiang H; Liang D
Elife; 2022 Jan; 11():. PubMed ID: 35001873
[TBL] [Abstract][Full Text] [Related]
3. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
4. Endothelial METTL3 (Methyltransferase-Like 3) Inhibits Fibrinolysis by Promoting PAI-1 (Plasminogen Activator Inhibitor-1) Expression Through Enhancing Jun Proto-Oncogene N6-Methyladenosine Modification.
Bai Q; Lu Y; Chen Y; Zhang H; Zhang W; Wu H; Wen A
Arterioscler Thromb Vasc Biol; 2021 Dec; 41(12):2877-2889. PubMed ID: 34645279
[TBL] [Abstract][Full Text] [Related]
5. METTL3/YTHDF2 m
Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
[TBL] [Abstract][Full Text] [Related]
6. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m
Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ
J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306
[TBL] [Abstract][Full Text] [Related]
7. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on
Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension.
Kang K; Xiang J; Zhang X; Xie Y; Zhou M; Zeng L; Zhuang J; Kuang J; Lin Y; Hu B; Xiong Q; Yin Q; Su Q; Liao X; Wang J; Niu Y; Liu C; Tian J; Gou D
Cell Mol Biol Lett; 2024 May; 29(1):69. PubMed ID: 38741032
[TBL] [Abstract][Full Text] [Related]
9. Dynamic m
Yang F; Jin H; Que B; Chao Y; Zhang H; Ying X; Zhou Z; Yuan Z; Su J; Wu B; Zhang W; Qi D; Chen D; Min W; Lin S; Ji W
Oncogene; 2019 Jun; 38(24):4755-4772. PubMed ID: 30796352
[TBL] [Abstract][Full Text] [Related]
10. METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export.
Li D; Cai L; Meng R; Feng Z; Xu Q
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121289
[TBL] [Abstract][Full Text] [Related]
11. RNA m
Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G
EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828
[TBL] [Abstract][Full Text] [Related]
12. Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis.
Dunn J; Qiu H; Kim S; Jjingo D; Hoffman R; Kim CW; Jang I; Son DJ; Kim D; Pan C; Fan Y; Jordan IK; Jo H
J Clin Invest; 2014 Jul; 124(7):3187-99. PubMed ID: 24865430
[TBL] [Abstract][Full Text] [Related]
13. Endothelial UCP2 Is a Mechanosensitive Suppressor of Atherosclerosis.
Luo JY; Cheng CK; He L; Pu Y; Zhang Y; Lin X; Xu A; Lau CW; Tian XY; Ma RCW; Jo H; Huang Y
Circ Res; 2022 Aug; 131(5):424-441. PubMed ID: 35899624
[TBL] [Abstract][Full Text] [Related]
14. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.
Feng Z; Li Q; Meng R; Yi B; Xu Q
J Cell Mol Med; 2018 May; 22(5):2558-2568. PubMed ID: 29502358
[TBL] [Abstract][Full Text] [Related]
15. METTL3/METTL14 Transactivation and m
Feng Y; Dong H; Sun B; Hu Y; Yang Y; Jia Y; Jia L; Zhong X; Zhao R
Cell Mol Gastroenterol Hepatol; 2021; 12(3):839-856. PubMed ID: 33992834
[TBL] [Abstract][Full Text] [Related]
16. The N
Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
[TBL] [Abstract][Full Text] [Related]
17. m6A-related bioinformatics analysis and functional characterization reveals that METTL3-mediated NPC1L1 mRNA hypermethylation facilitates progression of atherosclerosis via inactivation of the MAPK pathway.
Zhang G; Li X; Huang X
Inflamm Res; 2023 Mar; 72(3):429-442. PubMed ID: 36583755
[TBL] [Abstract][Full Text] [Related]
18. METTL3 Regulates Osteoblast Differentiation and Inflammatory Response via Smad Signaling and MAPK Signaling.
Zhang Y; Gu X; Li D; Cai L; Xu Q
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892163
[TBL] [Abstract][Full Text] [Related]
19. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.
Jian D; Wang Y; Jian L; Tang H; Rao L; Chen K; Jia Z; Zhang W; Liu Y; Chen X; Shen X; Gao C; Wang S; Li M
Theranostics; 2020; 10(20):8939-8956. PubMed ID: 32802173
[No Abstract] [Full Text] [Related]
20. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]